{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T08:02:18Z","timestamp":1781596938619,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2023307006"],"award-info":[{"award-number":["H2023307006"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>High-grade endometrial stromal sarcoma (HG-ESS) is a rare malignant tumor with poor prognosis. To overcome the limitations of current treatment for advanced patients, the intervention of targeted drug therapy is urgently needed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 74-year-old married woman who presented with abdominal distension and lower abdominal pain was admitted to Hebei General Hospital. After surgery, immunohistochemical staining revealed a malignant tumor which was consistent with HG-ESS. Tumor recurrence occurred 2 months after surgery. Then the patient underwent chemotherapy with two courses but responded poorly. Subsequently we observed <jats:italic>ATM<\/jats:italic>, <jats:italic>BLM<\/jats:italic>, and <jats:italic>CDH1<\/jats:italic> co-mutations by Next Generation Sequencing (NGS). Then the patient received pamiparib, which resulted in a 10-month progression-free survival (PFS) and is now stable with the administration of sintilimab in combination with pamiparib and anlotinib.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Due to the successful use of poly ADP-ribose polymerase inhibitor (PARPi) on HG-ESS, we suggest that the selection of effective targeted drugs combined with anti- programmed death-1 (PD-1) drug therapy based on genetic testing may become a new option for the treatment of homologous repair deficient (HR-deficient) HG-ESS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12877-024-05201-z","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T11:02:49Z","timestamp":1721041369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["ATM, BLM, and CDH1 gene co-mutations in a high-grade endometrial stromal sarcoma patient with multiple abdominal cavity metastases: a case report and literature review"],"prefix":"10.1186","volume":"24","author":[{"given":"Nan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congwei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"key":"5201_CR1","doi-asserted-by":"crossref","unstructured":"Gadducci A. Endometrial stromal tumors of the uterus: Epidemiology, pathological and biological features, treatment options and clinical outcomes. Gynecol Oncol. 2023.","DOI":"10.1016\/j.ygyno.2023.02.009"},{"key":"5201_CR2","doi-asserted-by":"publisher","first-page":"831","DOI":"10.2147\/CMAR.S187849","volume":"11","author":"YY Zhang","year":"2019","unstructured":"Zhang YY, Li Y, Qin M, Cai Y, Jin Y, Pan LY. High-grade endometrial stromal sarcoma: a retrospective study of factors influencing prognosis. Cancer Manag Res. 2019;11:831\u20137. https:\/\/doi.org\/10.2147\/CMAR.S187849.","journal-title":"Cancer Manag Res"},{"issue":"2","key":"5201_CR3","doi-asserted-by":"publisher","first-page":"e28490","DOI":"10.1097\/MD.0000000000028490","volume":"101","author":"H Bai","year":"2022","unstructured":"Bai H, Yuan F, Liang B, et al. Clinicopathological characteristics and treatment of patients with high-grade endometrial stromal sarcoma. Med (Baltim). 2022;101(2):e28490. https:\/\/doi.org\/10.1097\/MD.0000000000028490.","journal-title":"Med (Baltim)"},{"issue":"2","key":"5201_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ygyno.2017.05.036","volume":"146","author":"BLL Seagle","year":"2017","unstructured":"Seagle BLL, Shilpi A, Buchanan S, Goodman C, Shahabi S. Low-grade and high-grade endometrial stromal sarcoma: a National Cancer Database study. Gynecol Oncol. 2017;146(2):254\u201362. https:\/\/doi.org\/10.1016\/j.ygyno.2017.05.036.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"5201_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ygyno.2010.12.363","volume":"121","author":"LA Dos Santos","year":"2011","unstructured":"Dos Santos LA, Garg K, Diaz JP, et al. Incidence of lymph node and adnexal metastasis in endometrial stromal sarcoma. Gynecol Oncol. 2011;121(2):319\u201322. https:\/\/doi.org\/10.1016\/j.ygyno.2010.12.363.","journal-title":"Gynecol Oncol"},{"key":"5201_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2147\/IJWH.S117754","volume":"9","author":"C Benson","year":"2017","unstructured":"Benson C, Miah AB. Uterine sarcoma \u2013 current perspectives. Int J Womens Health. 2017;9:597\u2013606. https:\/\/doi.org\/10.2147\/IJWH.S117754.","journal-title":"Int J Womens Health"},{"issue":"8","key":"5201_CR7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1631\/jzus.B2000797","volume":"22","author":"C Li","year":"2021","unstructured":"Li C, Wang C. LG-ESSs and HG-ESSs: underlying molecular alterations and potential therapeutic strategies. J Zhejiang Univ-Sci B. 2021;22(8):633\u201346. https:\/\/doi.org\/10.1631\/jzus.B2000797.","journal-title":"J Zhejiang Univ-Sci B"},{"issue":"9","key":"5201_CR8","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.3390\/cancers12092604","volume":"12","author":"M Brahmi","year":"2020","unstructured":"Brahmi M, Franceschi T, Treilleux I, et al. Molecular classification of endometrial stromal sarcomas using RNA sequencing defines nosological and prognostic subgroups with different natural history. Cancers. 2020;12(9):2604. https:\/\/doi.org\/10.3390\/cancers12092604.","journal-title":"Cancers"},{"issue":"1","key":"5201_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/his.12594","volume":"67","author":"C Lee","year":"2015","unstructured":"Lee C, Nucci MR. Endometrial stromal sarcoma \u2013 the new genetic paradigm. Histopathology. 2015;67(1):1\u201319. https:\/\/doi.org\/10.1111\/his.12594.","journal-title":"Histopathology"},{"issue":"2","key":"5201_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000493322","volume":"96","author":"LT Juckett","year":"2019","unstructured":"Juckett LT, Lin DI, Madison R, Ross JS, Schrock AB, Ali S. A Pan-cancer Landscape Analysis reveals a subset of Endometrial Stromal and Pediatric tumors defined by Internal Tandem duplications of BCOR. Oncology. 2019;96(2):101\u20139. https:\/\/doi.org\/10.1159\/000493322.","journal-title":"Oncology"},{"issue":"11","key":"5201_CR11","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/gcc.22649","volume":"57","author":"BC Dickson","year":"2018","unstructured":"Dickson BC, Lum A, Swanson D, et al. Novel EPC1 gene fusions in endometrial stromal sarcoma. Genes Chromosomes Cancer. 2018;57(11):598\u2013603. https:\/\/doi.org\/10.1002\/gcc.22649.","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"5201_CR12","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/PAS.0000000000001215","volume":"43","author":"P Cotzia","year":"2019","unstructured":"Cotzia P, Benayed R, Mullaney K, et al. Undifferentiated uterine sarcomas represent underrecognized high-Grade Endometrial stromal sarcomas. Am J Surg Pathol. 2019;43(5):662\u20139. https:\/\/doi.org\/10.1097\/PAS.0000000000001215.","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"5201_CR13","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/modpathol.2017.42","volume":"30","author":"S Chiang","year":"2017","unstructured":"Chiang S, Lee CH, Stewart CJR, et al. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-Grade Endometrial stromal sarcoma, including tumors exhibiting variant morphology. Mod Pathol off J U S Can Acad Pathol Inc. 2017;30(9):1251\u201361. https:\/\/doi.org\/10.1038\/modpathol.2017.42.","journal-title":"Mod Pathol off J U S Can Acad Pathol Inc"},{"issue":"6","key":"5201_CR14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/PAS.0000000000001055","volume":"42","author":"S Chiang","year":"2018","unstructured":"Chiang S, Cotzia P, Hyman DM, et al. NTRK fusions define a novel uterine sarcoma subtype with features of Fibrosarcoma. Am J Surg Pathol. 2018;42(6):791\u20138. https:\/\/doi.org\/10.1097\/PAS.0000000000001055.","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"5201_CR15","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/s41379-018-0184-6","volume":"32","author":"S Croce","year":"2019","unstructured":"Croce S, Hostein I, Longacre TA, et al. Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms. Mod Pathol. 2019;32(7):1008\u201322. https:\/\/doi.org\/10.1038\/s41379-018-0184-6.","journal-title":"Mod Pathol"},{"key":"5201_CR16","doi-asserted-by":"publisher","first-page":"100523","DOI":"10.1016\/j.gore.2019.100523","volume":"31","author":"SL Grindstaff","year":"2019","unstructured":"Grindstaff SL, DiSilvestro J, Hansen K, DiSilvestro P, Sung CJ, Quddus MR. COL1A1-PDGFB fusion uterine fibrosarcoma: a case report with treatment implication. Gynecol Oncol Rep. 2019;31:100523. https:\/\/doi.org\/10.1016\/j.gore.2019.100523.","journal-title":"Gynecol Oncol Rep"},{"issue":"8","key":"5201_CR17","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1097\/PAS.0000000000001292","volume":"43","author":"M Michal","year":"2019","unstructured":"Michal M, H\u00e1jkov\u00e1 V, Sk\u00e1lov\u00e1 A, Michal M. STRN-NTRK3-rearranged mesenchymal tumor of the Uterus: expanding the morphologic spectrum of tumors with NTRK fusions. Am J Surg Pathol. 2019;43(8):1152\u20134. https:\/\/doi.org\/10.1097\/PAS.0000000000001292.","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"5201_CR18","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.7150\/ijbs.63963","volume":"17","author":"X Xie","year":"2021","unstructured":"Xie X, Zhang Y, Wang Z, et al. ATM at the crossroads of reactive oxygen species and autophagy. Int J Biol Sci. 2021;17(12):3080\u201390. https:\/\/doi.org\/10.7150\/ijbs.63963.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"5201_CR19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/ijms23010523","volume":"23","author":"S Ueno","year":"2022","unstructured":"Ueno S, Sudo T, Hirasawa A. ATM: functions of ATM kinase and its relevance to Hereditary tumors. Int J Mol Sci. 2022;23(1):523. https:\/\/doi.org\/10.3390\/ijms23010523.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"5201_CR20","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.21037\/atm-21-2884","volume":"9","author":"H Zhou","year":"2021","unstructured":"Zhou H, Chen H, Cheng C, et al. A quality evaluation of the clinical practice guidelines on breast cancer using the RIGHT checklist. Ann Transl Med. 2021;9(14):1174. https:\/\/doi.org\/10.21037\/atm-21-2884.","journal-title":"Ann Transl Med"},{"key":"5201_CR21","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/s12935-021-02210-5","volume":"21","author":"H Chen","year":"2021","unstructured":"Chen H, Ye Z, Xu X, et al. ALDOA inhibits cell cycle arrest induced by DNA damage via the ATM-PLK1 pathway in pancreatic cancer cells. Cancer Cell Int. 2021;21:514. https:\/\/doi.org\/10.1186\/s12935-021-02210-5.","journal-title":"Cancer Cell Int"},{"key":"5201_CR22","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1038\/s41598-021-83531-3","volume":"11","author":"RA Saunders","year":"2021","unstructured":"Saunders RA, Michniacki TF, Hames C, et al. Elevated inflammatory responses and targeted therapeutic intervention in a preclinical mouse model of ataxia-telangiectasia lung disease. Sci Rep. 2021;11:4268. https:\/\/doi.org\/10.1038\/s41598-021-83531-3.","journal-title":"Sci Rep"},{"issue":"11","key":"5201_CR23","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/s41436-021-01240-8","volume":"23","author":"B Dalmasso","year":"2021","unstructured":"Dalmasso B, Pastorino L, Nathan V, et al. Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia. Genet Med. 2021;23(11):2087\u201395. https:\/\/doi.org\/10.1038\/s41436-021-01240-8.","journal-title":"Genet Med"},{"issue":"5","key":"5201_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/jpm11050389","volume":"11","author":"YC Wang","year":"2021","unstructured":"Wang YC, Lee KW, Tsai YS, et al. Downregulation of ATM and BRCA1 predicts poor outcome in Head and Neck Cancer: implications for ATM-Targeted therapy. J Pers Med. 2021;11(5):389. https:\/\/doi.org\/10.3390\/jpm11050389.","journal-title":"J Pers Med"},{"issue":"18","key":"5201_CR25","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","volume":"373","author":"J Mateo","year":"2015","unstructured":"Mateo J, Carreira S, Sandhu S, et al. DNA-Repair defects and Olaparib in metastatic prostate Cancer. N Engl J Med. 2015;373(18):1697\u2013708. https:\/\/doi.org\/10.1056\/NEJMoa1506859.","journal-title":"N Engl J Med"},{"issue":"13","key":"5201_CR26","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1080\/14656566.2016.1217992","volume":"17","author":"K Young","year":"2016","unstructured":"Young K, Starling N, Cunningham D. Targeting deficient DNA damage repair in gastric cancer. Expert Opin Pharmacother. 2016;17(13):1757\u201366. https:\/\/doi.org\/10.1080\/14656566.2016.1217992.","journal-title":"Expert Opin Pharmacother"},{"issue":"11","key":"5201_CR27","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1002\/cncr.30631","volume":"123","author":"KJ Rimar","year":"2017","unstructured":"Rimar KJ, Tran PT, Matulewicz RS, Hussain M, Meeks JJ. The emerging role of homologous recombination repair and PARP inhibitors in Genitourinary malignancies. Cancer. 2017;123(11):1912. https:\/\/doi.org\/10.1002\/cncr.30631.","journal-title":"Cancer"},{"key":"5201_CR28","doi-asserted-by":"publisher","first-page":"808801","DOI":"10.3389\/fonc.2022.808801","volume":"12","author":"W Wang","year":"2022","unstructured":"Wang W, Zhang X, Fang Y, et al. Case Report: Olaparib shows satisfactory clinical outcomes against small cell esophageal carcinoma with ATM Mutation. Front Oncol. 2022;12:808801. https:\/\/doi.org\/10.3389\/fonc.2022.808801.","journal-title":"Front Oncol"},{"key":"5201_CR29","doi-asserted-by":"publisher","first-page":"17527","DOI":"10.1038\/s41598-019-54101-5","volume":"9","author":"RL Cox","year":"2019","unstructured":"Cox RL, Hofley CM, Tatapudy P, et al. Functional conservation of RecQ helicase BLM between humans and Drosophila melanogaster. Sci Rep. 2019;9:17527. https:\/\/doi.org\/10.1038\/s41598-019-54101-5.","journal-title":"Sci Rep"},{"issue":"2","key":"5201_CR30","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.trecan.2020.09.001","volume":"7","author":"A Datta","year":"2021","unstructured":"Datta A, Dhar S, Awate S, Brosh RM. Synthetic Lethal interactions of RECQ helicases. Trends Cancer. 2021;7(2):146\u201361. https:\/\/doi.org\/10.1016\/j.trecan.2020.09.001.","journal-title":"Trends Cancer"},{"key":"5201_CR31","doi-asserted-by":"publisher","first-page":"106433","DOI":"10.1016\/j.bpc.2020.106433","volume":"265","author":"A Mojumdar","year":"2020","unstructured":"Mojumdar A. Mutations in conserved functional domains of human RecQ helicases are associated with diseases and cancer: a review. Biophys Chem. 2020;265:106433. https:\/\/doi.org\/10.1016\/j.bpc.2020.106433.","journal-title":"Biophys Chem"},{"key":"5201_CR32","doi-asserted-by":"publisher","first-page":"107327482211294","DOI":"10.1177\/10732748221129451","volume":"29","author":"D Zhang","year":"2022","unstructured":"Zhang D, Xu X, Wei Y, et al. Prognostic role of DNA damage response genes mutations and their Association with the sensitivity of olaparib in prostate Cancer patients. Cancer Control J Moffitt Cancer Cent. 2022;29:10732748221129451. https:\/\/doi.org\/10.1177\/10732748221129451.","journal-title":"Cancer Control J Moffitt Cancer Cent"},{"key":"5201_CR33","unstructured":"Atkinson MJ, Reich U, Becker I. E-Cadherin Gene Mutations Provide Clues to Diffuse Type Gastric Carcinomas."},{"issue":"5","key":"5201_CR34","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3390\/genes13050803","volume":"13","author":"J Li","year":"2022","unstructured":"Li J, Lan M, Peng J, et al. Cdh1 Deficiency sensitizes TNBC cells to PARP inhibitors. Genes. 2022;13(5):803. https:\/\/doi.org\/10.3390\/genes13050803.","journal-title":"Genes"},{"issue":"7","key":"5201_CR35","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1158\/2159-8290.CD-17-0226","volume":"7","author":"KW Mouw","year":"2017","unstructured":"Mouw KW, Goldberg MS, Konstantinopoulos PA, D\u2019Andrea AD. DNA damage and repair biomarkers of Immunotherapy Response. Cancer Discov. 2017;7(7):675\u201393. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0226.","journal-title":"Cancer Discov"},{"issue":"12","key":"5201_CR36","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nri3921","volume":"15","author":"GN Barber","year":"2015","unstructured":"Barber GN. STING: infection, inflammation and cancer. Nat Rev Immunol. 2015;15(12):760\u201370. https:\/\/doi.org\/10.1038\/nri3921.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"5201_CR37","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.3390\/cancers12061502","volume":"12","author":"F Peyraud","year":"2020","unstructured":"Peyraud F, Italiano A, Combined PARP. Inhibition and Immune Checkpoint Therapy in Solid tumors. Cancers. 2020;12(6):1502. https:\/\/doi.org\/10.3390\/cancers12061502.","journal-title":"Cancers"},{"key":"5201_CR38","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1038\/s41598-019-38534-6","volume":"9","author":"Z Wang","year":"2019","unstructured":"Wang Z, Sun K, Xiao Y, et al. Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models. Sci Rep. 2019;9:1853. https:\/\/doi.org\/10.1038\/s41598-019-38534-6.","journal-title":"Sci Rep"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05201-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-024-05201-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05201-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T11:04:13Z","timestamp":1721041453000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-024-05201-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5201"],"URL":"https:\/\/doi.org\/10.1186\/s12877-024-05201-z","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]},"assertion":[{"value":"9 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Collection and use of patient samples were approved by The Ethics Committee of Hebei General Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained by the patient for publication of this report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"603"}}